-4.85%07-07“The echo of SK Hynix's IPO bell hadn't faded before one Korean research note yanked the whole memory complex back to earth — but a company that's pre-sold capacity through 2027 doesn't get sentenced on someone else's bad news; above $880 this is just the supercycle taking a deep breath”
Score8/10Day / week -4.3% / -7.0%RSI(14) 46.2WSB mentions 394 (nearly 2x in 24h, rank #1)SMA50 support $907Consensus target $1,579 (+68%)
Technicals — Pulled back to a step above the 50-day at $907 — the $920 add-watch zone flagged last issue has arrived. RSI at 46 is neutral and volume ran at just 0.7x, so the decline came without panic distribution. Overhead: the 20-day at $1,051 and the 52-week high at $1,255.
Fundamentals — Guidance was just raised on July 9 on surging memory pricing: cloud-memory revenue up 78% sequentially at an 83% gross margin, data-center revenue up 103%. HBM is sold out for 2026 and fully pre-sold through 2027. Nothing on this line changed today.
News — SK Hynix suffered its worst one-day drop on record (-15.4%) after Korean broker KIS cut its Q2 estimate 8% below consensus on slower HBM4 shipments, compounding post-Nasdaq-debut profit-taking; the KOSPI fell 9.95% and tripped a circuit breaker. US memory names sold off in sympathy — MU, SanDisk and WDC all took the hit.
Short-term · 1–3 weeks
LongBullish
Shrinking volume, 50-day support and zero fundamental change — all three marks of a pullback rather than a reversal. A break of $880 (half an ATR under the 50-day) would mean the market has started pricing a cycle top; execute the stop unconditionally there.
Entry Hold; $900–920 (the 50-day support band) is the add-watch zoneStop $880Target $1,150
Long-term · months+
Accumulate
Memory supercycle plus HBM pricing power; capacity pre-sold through 2027 gives rare revenue visibility, and the structural AI-memory shortage hasn't closed.
Signal BacktestCumulative -4.85%price itself -9.23%profitable since 07-10
07-07Long$984.75 → open → $937-4.85%
Community Voices
WSB · Mentions surged from 206 to 394 in 24h to take the #1 spot — bulls shouting 'gift dip' and bears shouting 'cycle top' in the same threadOriginal ↗
Institutional Views
华尔街共识 · 53 analysts average $1,579 — 68% above spot; 1.14 rating, near strong buy
TradingKey · The Anthropic deal plus a 22% pullback frame the buy-the-dip debateSource ↗
Motley Fool · The pricing cycle isn't done: prices still rising across the portfolio amid constrained supplySource ↗
New today“Mentions went from 1 to 138 overnight as the 0.7nm chip and a quantum foundry landed on the table together — the difference this time is a billion federal dollars of real skin in the game; revenue five years out, stock price today: give it small-position belief, not full-position faith”
Score7/10WSB mentions 138 (vs just 1 a day earlier)Tech breakthrough World's first sub-1nm 'nanostack' chipQuantum foundry Anderon: $1B from Commerce Dept + $1B from IBMEarnings 7/22Averages Above all MAs, bullish stack
Technicals — Up 0.9% against a broadly red tape. The 20/50/200-day averages ($277/$263/$275) are stacked bullishly and Friday's volume push cleared the 200-day; RSI at 56.7 is healthy with 12.7% of room to the $332 high — one of the few megacaps with both a story and a setup.
Fundamentals — The 0.7nm nanostack packs nearly 100 billion 3D-stacked transistors onto a fingernail — +50% performance or +70% efficiency, +40% SRAM density — with commercialization at least five years out. More tangible: the Anderon quantum foundry in Albany ($1B each from Commerce and IBM) sitting on the Red Hat/consulting cash-flow base.
News — Friday's unveiling of the world's first sub-1nm chip drove a 4.75% volume breakout, and with the cyber alliance plus federal quantum backing, retail chatter detonated overnight. Next stop: July 22 earnings — the narrative needs numbers to take the baton.
Short-term · 1–2 weeks (into 7/22 earnings)
LongLean bullish
Counter-tape strength, a bullish MA stack and a dated catalyst (7/22) all line up; the $275 stop sits under the 20-day/200-day cluster. This trade harvests narrative fermentation, not valuation — earnings day is settlement day, don't overstay.
Entry Pullbacks to $284–290 stay inside the structure; halve the position before earningsStop $275Target $310
Long-term · months+
Neutral
Quantum and advanced nodes are five-year options with some premium already in the price; the Red Hat/consulting cash flows anchor the core case, and the 200-day area — not here — is where long-term money belongs.
A 7/22 earnings miss punctures the hype directly
Quantum/advanced-node commercialization slipping
Catch-down risk in a broader risk-off
Community Voices
WSB · Mentions went 1→138: from ignored to everywhere in one weekend — hype is fuel and altitude at once; check your parachute before boardingOriginal ↗
StockTwits · Trending at 18.9 on the triple narrative of target hikes, federal quantum money and the sub-1nm chip — breakout believers vs the 'five years is forever' camp, head onOriginal ↗
Institutional Views
华尔街共识 · 27 analysts average $300 — just 3.5% above spot; note the consensus hasn't digested the new narrative yet, so treat that number lightly
Barchart · Sub-1nm is a lab milestone pushing past AI limits; the road to revenue remains longSource ↗
Simply Wall St · Sub-1nm launch plus the quantum wafer foundry opening — both catalysts have landedSource ↗
+4.47%07-04“Korea hit the circuit breaker and the arms dealer only caught a stray round — $196 is the verdict line: above it this is a gift dip, below it a new story begins; don't pronounce sentence on your own position before the market does”
Score7/10Day / week -3.5% / +4.7%RSI(14) 49.9Stop $196 (above the 200-day at $191.8)WSB mentions 115 (3.3x)Consensus target $314 (+54%)
Technicals — Even after the 3.5% giveback the week is still +4.7%, holding a step above the 20-day at $201.9; volume at 0.84x shows no loosening of the holder base. The $196 stop sits in the buffer above the 200-day at $191.8 — a clean structure.
Fundamentals — The arms-dealer logic is untouched: Meta's 14GW, Microsoft and Anthropic are all still building. HBM sits on NVIDIA's cost line, so a cooling memory market is neutral-to-positive for margins — and its order visibility remains the best in the market.
News — Korea's semiconductor circuit-breaker rippled through the global compute chain; with zero company-specific negatives, the 3.5% dip is pure sentiment contagion — and WSB chatter has flipped from 'it's up too much' to 'do we buy this dip.'
Short-term · 1–3 weeks
LongBullish
Stray rounds hurt sentiment, not the order book. The stop hugs the 200-day's upper rim and the break-means-exit discipline stands — let $196 make the decision, not the panic.
Entry Hold; a stabilized retest of $200 (20-day plus round-number support) is the re-entry spotStop $196Target $235
Long-term · months+
Accumulate
The only full-stack arms dealer in the AI compute race, with platform lock-in (CUDA + networking + systems) still deepening.
HBM supply bottlenecks pacing shipments
Hyperscaler in-house silicon diverting spend
Export-control escalation
Signal BacktestCumulative +4.47%price itself +3.01%profitable since 07-07
07-04Long$194.83 → open → $203.53+4.47%
Community Voices
WSB · Mentions went 35→115: one red day tripled the chatter — it's still everyone's frame of referenceOriginal ↗
Institutional Views
华尔街共识 · 66 analysts average $314 — 54% above spot; 1.14 rating, near strong buy
-5.96%07-07“1.2% from the stop with an $18.6 ATR — one ordinary swing can trigger the exit, so every day into 7/22 is a tightrope walk; the 480k-delivery card has already been played, and what earnings will flip over is the margin hole card — right now discipline is worth more than faith”
Score7/10To the stop $390 — just 1.2% awayEarnings 7/22Q2 deliveries 480,126 (+25%, beat by ~74k)RSI(14) 47.2ATR $18.6
Technicals — Down 3.2% through the 20-day at $400.7 with the $390 stop right in its face; 0.7x volume shows no active flight — but no bid either. The 50-day at $409.6 and 200-day at $418 cap the upside in sequence.
Fundamentals — Q2's 480,126 deliveries were the strongest second quarter ever and the first year-over-year growth in two years; the only question for 7/22 is whether that volume was bought with margin (price cuts / financing subsidies). EPS consensus sits flat at $0.27.
News — No company-specific negatives — just tape sympathy. The stock popped 6.6% on July 6 on robotaxi progress and the delivery beat; into earnings, the market keeps repricing the same hand.
Short-term · Into 7/22 earnings
LongBullish
The stop is 1.2% away: if it triggers, walk — earnings are the next train. If it holds, the trend is intact and the position rides unchanged into 7/22. The delivery beat is priced; earnings bet the margin, and that's not this position's wager.
Entry Hold as-is, no adds, no trims; a $390 break means exit immediately — don't wait for earningsStop $390Target $430
Long-term · months+
Neutral
Robotaxi/FSD and storage are real second curves, but the valuation already carries heavy option value; long-term money should wait for the margin answer at earnings.
Margin miss
Brand risk from Musk's political exposure
Global squeeze from Chinese OEMs
Signal BacktestCumulative -5.96%price itself -7.18%
07-07Long$419.77 → open → $394.76-5.96%
Institutional Views
华尔街共识 · 51 analysts average $407 — only 3.2% above spot at a 1.77 rating; the consensus is no longer cheap, and all the disagreement is stacked on the earnings table
Electrek · Q2 deliveries of 480,126, up 25% — a big beatSource ↗
New today“The CXO duo has one name printing highs and the other pressed against them — Asymchem is up 39% in a month with HK$130 one kick away. There's no shame in buying a breakout; the shame is buying one without a stop. Below HK$115, this story is no longer yours”
Score7/101-month +38.7%To 52-wk high HK$130 — one step awayRSI(14) 66.8Sector echo WuXi Bio (2269, held) printing highs in tandemBank target avg HK$136.1
Technicals — A fully bullish MA stack (20-day HK$108, 50-day HK$101, 200-day HK$89), with this morning's 4.9% push on 1.24x volume pressing the HK$130 prior high. This isn't a one-day melt-up chase — it's a month of stair-step gains, and RSI at 66.8 is warm, not burnt.
Fundamentals — CXO demand is flowing back — innovative-drug licensing plus a warming peptide/small-molecule order cycle has made interim-season order visibility a safe-harbor theme for HK money. The July 8 H-share incentive grant (at RMB 1.00) locks in the core team.
News — Shares rose 6.7% on July 9 when the incentive grant was disclosed; with WuXi Bio printing highs in tandem, CXO is one of the few long themes on a red tech tape. Two bank buy ratings in 90 days, average target HK$136.1.
Short-term · 1–3 weeks
LongLean bullish
Breakout channel, sector confirmation (2269 at highs too) and a stair-step monthly climb — triple confirmation. The HK$115 stop allows 1.5 ATRs (HK$8.75); a break means being wrong, and the entire dignity of new-high trading lives in the stop.
Entry Scale in inside HK$122–128; a volume close above HK$130 confirms the breakoutStop HK$115Target HK$145
Long-term · months+
Accumulate
A warming CXO cycle with rising utilization, big order elasticity in peptides (GLP-1 spillover), and the RMB-1 incentive grant aligning management.
雪球 · CXO chatter is heating up — bagholders from the last cycle top are still lecturing new buyers, which is the standard soundtrack of an advance's first halfOriginal ↗
Institutional Views
华尔街共识 · 7 analysts average HK$133 — 4.2% above spot at a 1.07 rating; targets are being chased higher by the price
搜狐财经 · H-share incentive granted; two buy ratings in 90 days with an average target of HK$136.1Source ↗
+10.77%07-02“After a 15% week, one flat day is a rest, not a reversal — and closing flat while HS Tech bled is independence worth more than the gain itself; with the stop lifted above cost, others fight vertigo while you just read the ledger”
Technicals — A quiet consolidation after the 15% week: the 7-day RSI at 74.8 is short-term hot but the daily RSI of 56 is healthy. The 20-day sits far below at HK$101.4 with the 50-day at HK$116.8 as the next gate. Flat this morning against a falling tech index — relative strength intact.
Fundamentals — The FY27Q1 preview points to cloud growth accelerating to ~45% (above expectations) with EBITA margin reaching low double digits; Qwen 4.0 plus the QoderWork/Wukong/MuleRun productivity suite gives the 'reprice AI assets' narrative something real to hold.
News — After the two-stage jump (+12% on 7/8, +5% on 7/9), rotation has settled in and the banks' 'time to reprice AI assets' call keeps working; a flat close on a red HS Tech morning says the holder base hasn't loosened.
Short-term · 1–3 weeks
LongBullish
Low-volume consolidation after a surge is a bullish shape, counter-tape strength is valuable, and the stop already sits above cost — this is the textbook let-it-run setup, not a take-profit one.
Entry Hold; a pullback to HK$105–107 remains the only dignified boarding zone for those who missed itStop HK$105Target HK$130
Long-term · months+
Accumulate
The cloud+AI re-rating is still early with a valuation discount to US peers as the cushion; core-commerce cash flow funds the capex cycle.
LLM monetization underdelivering
Regulatory whiplash
Weak consumption dragging the core
Signal BacktestCumulative +10.77%price itself +17.75%0/1 closed trades wonprofitable since 07-09
07-02LongHK$94.5 → closed HK$94.107-04-0.42%
07-08LongHK$99.6 → open → HK$110.8+11.24%
Community Voices
雪球 · The 'phase two of the AI re-rating' camp battles the 'take the money' camp — the sidelined wait for a dip, and a dip that never comes is the market's cruelest trickOriginal ↗
